Characteristics of patients (pts) and prognostic factors across treatment lines (TL) in metastatic colorectal cancer (mCRC): An analysis from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.

被引：2

作者：

Bachet, Jean-Baptiste

Chibaudel, Benoist

Rakez, Manel

Goldberg, Richard M.

Tebbutt, Niall C.

Van Cutsem, Eric

Haller, Daniel G.

Hecht, J. Randolph Randolph

Mayer, Robert J.

Lichtman, Stuart M.

Benson, Al

Sobrero, Alberto F.

Tabernero, Josep

Adams, Richard

Zalcberg, John Raymond

Grothey, Axel

Yoshino, Takayuki

Shi, Qian

De Gramont, Aimery

机构：

[1] Hop La Pitie Salpetriere, Paris, France

[2] Franco British Inst, Levallois Perret, France

[3] ARCAD Fdn, Stat Unit, Levallois Perret, France

[4] West Virginia Univ, Inst Canc, Morgantown, WV 26506 USA

[5] Austin Hlth, Olivia Newton John Canc Wellness & Res Ctr, Heidelberg, Vic, Australia

[6] Univ Hosp Gasthuisberg, Leuven, Belgium

[7] Katholieke Univ Leuven, Leuven, Belgium

[8] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[9] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[10] Dana Farber Canc Inst, Boston, MA 02115 USA

[11] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[12] Northwestern Med, Chicago, IL USA

[13] IRCCS Osped Policlin San Martino, Genoa, Italy

[14] Vall dHebron Univ Hosp, Barcelona, Spain

[15] UVic UCC, Vall dHebron Inst Oncol VHIO, Barcelona, Spain

[16] Cardiff Univ, Cardiff, Wales

[17] Velindre Canc Ctr, Cardiff, Wales

[18] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[19] West Canc Ctr, OneOncol, Germantown, TN USA

[20] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[21] Mayo Clin, Rochester, MN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.3575

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3575

引用

页数：3

共 50 条

[31] Early predictors of improved long-term outcomes in first-line antiangiogenics plus chemotherapy (anti-ANG/CT) in metastatic colorectal cancer (mCRC): Analysis of individual patient (pt) data from the ARCAD database.
Saad, Everardo D.
Coart, Elisabeth
Sommeijer, Dirkje Willemien
Shi, Qian
Zalcberg, John Raymond
Burzykowski, Tomasz
Meyers, Jeffrey P.
Hoff, Paulo Marcelo
Hecht, J. Randolph
Hurwitz, Herbert
Tol, Jolien
Tebbutt, Niall C.
Fuchs, Charles S.
Diaz-Rubio, Eduardo
Souglakos, John
Falcone, Alfredo
Kabbinavar, Fairooz F.
Sargent, Daniel J.
De Gramont, Aimery
Buyse, Marc E.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[32] PROGNOSTIC VALUE OF EARLY OBJECTIVE TUMOR RESPONSE (EOTR) TO FIRST LINE SYSTEMIC THERAPY IN METASTATIC COLORECTAL CANCER (MCRC): INDIVIDUAL PATIENT DATA (IPD) META-ANALYSIS OF RANDOMIZED TRIALS FROM THE ARCAD DATABASE
Sommeijer, Dirkje W.
Shi, Qian
Meyer, Jeffrey
Sjoquist, Katrin M.
Hoff, Paolo M.
Seymour, Matthew T.
Cassidy, Jim
Goldberg, Richard
Douillard, Jean-Yves
Hecht, J. Randolph
Hurwitz, Herbert
Tournigand, Christophe
Tebbutt, Niall C.
Aranda, Enrique
Souglakos, John
Kabbinavar, Fairooz F.
Chibaudel, Benoist
De Gramont, Aimery
Sargent, Daniel J.
Zalcberg, John
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 76 - 76
[33] Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database
van Rooijen, K. L.
Shi, Q.
Goey, K. K. H.
Meyers, J.
Heinemann, V.
Diaz-Rubio, E.
Aranda, E.
Falcone, A.
Green, E.
de Gramont, A.
Sargent, D. J.
Punt, C. J. A.
Koopman, M.
EUROPEAN JOURNAL OF CANCER, 2018, 91 : 99 - 106
[34] First-line treatment outcomes according to cfDNA analysis of RAS mutation status in metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study
Garcia Alfonso, P.
Valladares-Ayerbes, M.
Munoz Luengo, J.
Pimentel, P.
Vieitez, J. M.
Cruz Hernandez, J. J.
Llanos, M.
Garcia Giron, C.
Salud Salvia, A.
Lloansi Vila, A.
ANNALS OF ONCOLOGY, 2018, 29 : 183 - 183
[35] Updated analysis of a phase II study (20060314) of panitumumab (pmab) with FOLFIRI as first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC)
Greil, R.
Letocha, H.
Gamelin, E.
Thaler, J.
Hofheinz, R.
Mineur, L.
Fernebro, E.
Karthaus, M.
Wright, L.
Koehne, C.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[36] How to improve toxicity evaluation in clinical trials? Testing new metrics from irinotecan or oxaliplatin-based treatments in metastatic colorectal cancer (mCRC): A pooled analysis from 2,349 patients in ARCAD database
Tournigand, Christophe
Lopes, Guilherme
Olswold, Curtis L.
Adams, Richard
Zalcberg, John Raymond
Van Cutsem, Eric
Saltz, Leonard B.
Goldberg, Richard M.
Hurwitz, Herbert
Bokemeyer, Carsten
Fuchs, Charles S.
Chibaudel, Benoist
Grothey, Axel
De Gramont, Aimery
Shi, Qian
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[37] Characteristics of long-versus short-surviving patients (Pts): An analysis of the ARIES Observational Cohort Study (OCS) of bevacizumab (BV)-treated pts with metastatic colorectal cancer (mCRC).
Kozloff, Mark
Grothey, Axel
Bendell, Johanna C.
Cohn, Allen Lee
Bekaii-Saab, Tanios S.
Roach, Nancy
Flick, Elizabeth Dawn
Mun, Yong
Fish, Susan Meredith
Laeufle, Rita
Sommer, Nicolas
Hurwitz, Herbert
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
[38] Treatment with capecitabine (X) improves quality of life (QOL) in patients (PTS) with metastatic colorectal cancer (MCRC): Updated findings from a large cohort of 1437 PTS in Brazil with analysis as a function of ECOG PS
Beato, Carlos
VanEyll, Brigitte
Federico, Mirian
Skare, Nills
Franke, Fabio
Perdicaris, Martha
Tosello, Celia
Gampel, Otavio
Cabral, Sebastiao
Ribeiro, Ronaldo
ANNALS OF ONCOLOGY, 2006, 17 : 118 - 119
[39] Panitumumab (pmab) in patients (pts) with chemorefractory metastatic colorectal cancer (mCRC): Final analysis from a community-based, observational study (VECTOR) in Germany
Lerchenmuller, Christian A.
Groschek, Matthias
Kroening, Hendrik
Scheuer, Burkhard
Stauch, Martina
Kuhn, Anja
Hellebrand, Eva
Vehling-Kaiser, Ursula
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
[40] CHARACTERISTICS AND TREATMENT PATTERNS AMONG PATIENTS DIAGNOSED WITH METASTATIC COLORECTAL CANCER IN THE UNITED STATES: A HEALTHCARE CLAIMS DATABASE ANALYSIS
Hsu, L., I
Palanca-Wessels, M. C.
Stecher, M.
Siadak, M.
Surinach, A.
Arndorfer, S.
DeBusk, K.
VALUE IN HEALTH, 2021, 24 : S48 - S49

← 1 2 3 4 5 →